Peptide pharmaceutical formulations

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/30 (2006.01) A61K 38/25 (2006.01) A61K 38/26 (2006.01) A61K 38/29 (2006.01) A61K 47/12 (2006.01) A61K 47/26 (2006.01) A61M 5/142 (2006.01)

Patent

CA 2380423

A pharmaceutical composition for administration to a mammal is disclosed. The composition includes a therapeutically effective amount of a peptide, such as a GLP-1 molecule, a PTH molecule, or a GRF molecule. The composition further includes a buffer including a weak acid having an acid dissociation constant value of greater than about 1x10-5, such as acetic acid. The composition also includes an excipient for making the composition generally isotonic, such as D- mannitol.

L'invention concerne une composition pharmaceutique destinée à être administrée à un mammifère. La composition comprend une quantité efficace sur le plan thérapeutique d'un peptide, tel qu'une molécule GLP-1, une molécule PTH ou une molécule GRF. La composition comprend en outre un tampon renfermant un acide faible ayant une valeur constante de dissociation d'acide supérieure à environ 1x10?-5¿, tel qu'un acide acétique. La composition comprend également un excipient permettant de rendre la composition généralement isotonique, telle que D-mannitol.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Peptide pharmaceutical formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide pharmaceutical formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide pharmaceutical formulations will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1435215

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.